SAN ANTONIO — Although one state has authorized medical cannabis as a treatment for obstructive sleep apnea (OSA), the science supporting it remains shaky and physicians should be very cautious about recommending it, a sleep medicine specialist said here.
“The evidence is starting to come in, but it is still limited,” said Kannan Ramar, MD, of the Mayo Clinic Rochester, speaking Tuesday at SLEEP 2019, the joint meeting of the American Academy of Sleep Medicine (AASM) and the Sleep Research Society.
Ramar was lead author of an official AASM position statement published last year, issued after Minnesota approved OSA as a qualifying condition for medical cannabis.
“Based on the available evidence, it is the position of the AASM that medical cannabis should not be used for the treatment of OSA,” the statement read. “The AASM also advises state legislators, regulators, and health departments that OSA should not
... read more at: https://www.medpagetoday.com/meetingcoverage/apss/80422